SAN DIEGO & RALEIGH, N.C.--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP reminds investors that purchasers of Ekso Bionics Holdings, Inc. (NasdaqCM: EKSO) filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between March 15, 2017 and December 27, 2017. Ekso designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa.
View this information on the law firm's Shareholder Rights Blog: www.robbinsarroyo.com/ekso-bionics-holdings-inc-july-2018
Ekso Accused of Implementing Unreliable Internal Controls
On December 14, 2017, Ekso disclosed that its internal control over financial reporting as of December 31, 2016 should not be relied upon. According to the complaint, Ekso cited a reevaluation of the company's information technology controls by the company's auditor. On December 27, 2017, Ekso filed its amended annual report for 2016 and amended quarterly reports for the first three quarters of 2017. Since news of Ekso's financial troubles became public, the company's stock declined nearly 25%, and has yet to recover, closing at $1.86 per share on July 3, 2018.
Ekso Shareholders Have Legal Options
If you would like more information about your rights and potential remedies, contact attorney Leonid Kandinov at (800) 350-6003, LKandinov@robbinsarroyo.com, or via the shareholder information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.
Attorney Advertising. Past results do not guarantee a similar outcome.